Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

Atopic dermatitis (AD) is a common, heterogeneous, inflammatory skin disorder characterized by chronic or relapsing eczematous lesions with intense pruritus and discomfort. Affected patients often experience significant impairment in their quality of life, and the treatment of moderate-to-severe AD...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardo, Diana, Bieber, Thomas, Torres, Tiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460333/
https://www.ncbi.nlm.nih.gov/pubmed/37266844
http://dx.doi.org/10.1007/s40257-023-00793-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460333/
https://www.ncbi.nlm.nih.gov/pubmed/37266844
http://dx.doi.org/10.1007/s40257-023-00793-5

Ejemplares similares